Zoetis
ZTS
#443
Rank
A$79.59 B
Marketcap
A$179.60
Share price
-1.46%
Change (1 day)
-33.07%
Change (1 year)

Revenue for Zoetis (ZTS)

Revenue in 2025 (TTM): A$14.65 Billion

According to Zoetis's latest financial reports the company's current revenue (TTM ) is A$14.22 Billion. In 2024 the company made a revenue of A$14.88 Billion an increase over the revenue in the year 2023 that were of A$12.54 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Zoetis from 2011 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$14.65 B-1.54%
2024 A$14.88 B18.66%
2023 A$12.54 B5.62%
2022 A$11.87 B10.7%
2021 A$10.72 B23.56%
2020 A$8.68 B-2.91%
2019 A$8.94 B8.13%
2018 A$8.26 B21.64%
2017 A$6.79 B0.25%
2016 A$6.78 B3.67%
2015 A$6.54 B11.87%
2014 A$5.84 B14.34%
2013 A$5.11 B22.55%
2012 A$4.17 B1.07%
2011 A$4.12 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
A$89.94 B 532.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$97.23 B 583.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$95.03 B 568.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Phibro Animal Health
PAHC
A$2.11 B-85.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Kindred Biosciences
KIN
A$11.99 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Heska Corporation
HSKA
A$0.38 B-97.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$71.93 B 405.75%๐Ÿ‡ซ๐Ÿ‡ท France